We welcome this suggestion and subsequent discussions, and agree that resistance 23 gene nomenclature systems need updating and aligning in order to address the 24 increasing availability of genetic data and our understanding of the molecular 25 evolution of resistance genes. We would, however, like to add a note of caution that 26 the arbitrary >2% cut-off may not be universally appropriate. 27
28
In the case of the tetracycline resistance genes, covering the three known 29 mechanistic classes of protein (ATP-dependant efflux, ribosomal protection and 30 enzymatic inactivation), the nomenclature system is based on amino acid identity. A 31 new determinant must show <80% amino acid identity to known determinants to be 32 designated a new class. We propose here to contact all investigators involved in the historical and current 54 discovery, annotation, naming and curation of tetracycline resistance genes, and will 55 facilitate a discussion in order to determine if there is a consensus on any proposed 56 change to the current nomenclature system. We urge stakeholders to contact the 57 authors of this comment in order to indicate their interest in participation. Following 58 this process, we will report any agreement or hurdles perceived within the field. We 59 suggest other investigators involved in the nomenclature of other resistance genes 60 do the same and it is possible that these subgroups could form the basis of a larger 61 committee as proposed by Evans. 
